Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT

20th Dec 2018 13:19

FORM 8.3

Amendment to Sales

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 18 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,963,592 1.53% 14,742,881 1.86%
(2) Cash-settled derivatives:
14,675,153 1.85% 11,401,325 1.43%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,514,600 1.32% 10,514,600 1.32%
(4)
TOTAL: 37,153,345 4.70% 36,658,806 4.61%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 6,500 15.8138 USD
ADR Purchase 58,500 15.6016 USD
ADR Purchase 132,218 15.6075 USD
ADR Sale 6,500 15.8138 USD
ADR Sale 39,767 15.6962 USD
ADR Sale 58,500 15.6017 USD
ADR Sale 132,218 15.6075 USD
Ordinary NPV Purchase 400 3,677.5000 JPY
Ordinary NPV Purchase 500 3,636.0000 JPY
Ordinary NPV Purchase 800 3,637.6250 JPY
Ordinary NPV Purchase 1,500 3,692.0000 JPY
Ordinary NPV Purchase 1,600 3,590.0000 JPY
Ordinary NPV Purchase 1,900 3,671.2631 JPY
Ordinary NPV Purchase 2,300 3,656.3173 JPY
Ordinary NPV Purchase 2,300 3,700.0000 JPY
Ordinary NPV Purchase 2,700 3,718.6652 JPY
Ordinary NPV Purchase 2,700 3,650.9296 JPY
Ordinary NPV Purchase 3,300 3,650.0181 JPY
Ordinary NPV Purchase 4,000 3,630.0000 JPY
Ordinary NPV Purchase 6,000 3,704.0000 JPY
Ordinary NPV Purchase 6,700 3,622.5522 JPY
Ordinary NPV Purchase 7,200 3,674.3194 JPY
Ordinary NPV Purchase 9,500 3,649.3736 JPY
Ordinary NPV Purchase 12,600 3,663.0079 JPY
Ordinary NPV Purchase 17,700 3,650.8728 JPY
Ordinary NPV Purchase 20,300 3,658.4458 JPY
Ordinary NPV Purchase 29,500 3,657.9152 JPY
Ordinary NPV Purchase 57,100 3,617.0928 JPY
Ordinary NPV Purchase 90,000 3,720.5300 JPY
Ordinary NPV Purchase 114,600 3,683.8167 JPY
Ordinary NPV Purchase 168,300 3,664.2572 JPY
Ordinary NPV Purchase 183,400 3,663.1673 JPY
Ordinary NPV Purchase 277,500 3,671.7924 JPY
Ordinary NPV Purchase 296,900 3,681.9706 JPY
Ordinary NPV Purchase 835,400 3,679.7169 JPY
Ordinary NPV Purchase 849,800 3,680.6068 JPY
Ordinary NPV Sale 100 3,617.4000 JPY
Ordinary NPV Sale 424 3,688.5590 JPY
Ordinary NPV Sale 500 3,636.0000 JPY
Ordinary NPV Sale 560 3,662.0321 JPY
Ordinary NPV Sale 800 3,637.6250 JPY
Ordinary NPV Sale 1,900 3,661.4211 JPY
Ordinary NPV Sale 2,100 3,665.2857 JPY
Ordinary NPV Sale 2,300 3,656.3173 JPY
Ordinary NPV Sale 2,700 3,650.9296 JPY
Ordinary NPV Sale 2,900 3,684.3793 JPY
Ordinary NPV Sale 2,900 3,586.0000 JPY
Ordinary NPV Sale 2,961 3,722.4913 JPY
Ordinary NPV Sale 3,200 3,590.0000 JPY
Ordinary NPV Sale 3,200 3,651.0375 JPY
Ordinary NPV Sale 3,395 3,658.6727 JPY
Ordinary NPV Sale 3,649 3,648.8522 JPY
Ordinary NPV Sale 4,387 3,633.0305 JPY
Ordinary NPV Sale 5,133 3,671.7138 JPY
Ordinary NPV Sale 5,147 3,651.1210 JPY
Ordinary NPV Sale 6,000 3,593.1500 JPY
Ordinary NPV Sale 6,900 3,663.3371 JPY
Ordinary NPV Sale 7,200 3,674.3194 JPY
Ordinary NPV Sale 7,500 3,624.7200 JPY
Ordinary NPV Sale 7,600 3,686.5394 JPY
Ordinary NPV Sale 8,826 3,669.8272 JPY
Ordinary NPV Sale 9,500 3,649.3736 JPY
Ordinary NPV Sale 10,500 3,637.7142 JPY
Ordinary NPV Sale 12,600 3,663.0079 JPY
Ordinary NPV Sale 12,700 3,664.0393 JPY
Ordinary NPV Sale 17,700 3,650.8728 JPY
Ordinary NPV Sale 18,000 3,593.9333 JPY
Ordinary NPV Sale 20,000 3,725.5450 JPY
Ordinary NPV Sale 20,300 3,658.4458 JPY
Ordinary NPV Sale 20,400 3,700.5441 JPY
Ordinary NPV Sale 20,518 3,638.8021 JPY
Ordinary NPV Sale 26,000 3,648.9423 JPY
Ordinary NPV Sale 28,000 3,721.5214 JPY
Ordinary NPV Sale 32,700 3,714.8440 JPY
Ordinary NPV Sale 65,300 3,652.4793 JPY
Ordinary NPV Sale 79,800 3,682.8320 JPY
Ordinary NPV Sale 114,600 3,683.4319 JPY
Ordinary NPV Sale 149,342 3,598.1959 JPY
Ordinary NPV Sale 696,100 3,678.4986 JPY
Ordinary NPV Sale 835,400 3,679.7169 JPY
Ordinary NPV Sale 1,037,000 3,677.5820 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 400 3,687.0000 JPY
Ordinary NPV SWAP Long 424 3,688.5595 JPY
Ordinary NPV SWAP Long 560 3,662.0324 JPY
Ordinary NPV SWAP Long 1,900 3,720.0431 JPY
Ordinary NPV SWAP Long 2,961 3,722.4912 JPY
Ordinary NPV SWAP Long 3,395 3,658.6728 JPY
Ordinary NPV SWAP Long 3,649 3,648.8522 JPY
Ordinary NPV SWAP Long 4,387 3,633.0304 JPY
Ordinary NPV SWAP Long 5,133 3,671.7138 JPY
Ordinary NPV SWAP Long 5,147 3,651.1209 JPY
Ordinary NPV SWAP Long 6,900 3,663.3369 JPY
Ordinary NPV SWAP Long 8,826 3,669.8271 JPY
Ordinary NPV SWAP Long 20,518 3,638.8020 JPY
Ordinary NPV CFD Long 32,900 3,719.9441 JPY
Ordinary NPV CFD Long 66,700 3,684.1359 JPY
Ordinary NPV SWAP Short 100 3,590.0000 JPY
Ordinary NPV SWAP Short 2,100 3,715.8338 JPY
Ordinary NPV SWAP Short 2,700 3,718.6654 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 20 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Written 10,000,000 4206.0397 European 7 Jan 2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005393/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value9,321.40
Change12.20